2010-13519. Disease, Disability, and Injury Prevention and Control Special Interest Projects (SIPs): Examining the Impact of Cognitive Impairment on Co-Occurring Chronic Conditions SIP 10-037 and Epidemiologic Follow-Up Study of Newly Diagnosed ...

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:

Time and Date: 8:30 a.m.-6 p.m., June 23, 2010 (Closed).

Place: W Hotel—Buckhead, 3377 Peachtree Road, NE., Atlanta, GA 30326, [phone].

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to “Examining the Impact of Cognitive Impairment on Co-Occurring Chronic Conditions SIP 10-037 and Epidemiologic Follow-up Study of Newly Diagnosed Epilepsy SIP 10-039.”

Contact Person for More Information: Michelle Mathieson, Public Health Analyst, National Center for Chronic Disease and Health Promotion, Office of the Director, Extramural Research Program Office, CDC, 4770 Buford Highway, NE., Mailstop K-92, Atlanta, GA 30341, Telephone: [phone], E-mail: [e-mail].

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: May 28, 2010.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.